VENBIO GLOBAL STRATEGIC GP III, L.P.'s Net Worth

$0

Estimate Recalculated Nov 1, 2024 05:20AM EST

Who is VENBIO GLOBAL STRATEGIC GP III, L.P.?

VENBIO GLOBAL STRATEGIC GP III, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RayzeBio, Inc., Ventyx Biosciences, Inc., Elevation Oncology, Inc., and Artiva Biotherapeutics, Inc..

SEC CIK

VENBIO GLOBAL STRATEGIC GP III, L.P.'s CIK is 0001869303

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RayzeBio, Inc. (RYZB) No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5.16M
—
—
5.16M
Sep 19
Form 3
—
0
—
—
0
No matching records found

Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.0801

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 9
Form 4
∞
4M
$16.00
—
4M
Oct 25
Form 3
—
0
—
—
0
No matching records found

Elevation Oncology, Inc. (ELEV) Snapshot price: $0.6896

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-26.94%
-702.74K
$4.12
-$2,897,806.29
1.91M
May 25
Form 4
∞
2.61M
$16.00
—
2.61M
Jun 29
Form 3
—
0
—
—
0
No matching records found

Artiva Biotherapeutics, Inc. (ARTV) Snapshot price: $11.91

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.94M
$12.00
—
1.94M
Jul 22
Form 3
—
0
—
—
0
No matching records found